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Smmary This study examines the prognostic value ofclinical assessments, including a 3-fold classification of
cancer patients by treatment intention. It is based upon a sample of253 patients with different cancer diagnoses
who filled out a 108-item questionnaire. Cox regression analysis (the proportional hazards model) was used to
analyse the relationship of the three groups of covariates (clinical, demographic and psychosocial) with
survival. The univariate analysis showed that several clinical, demographic and psychosocial covariates are
significantly related to survival. The study located two main prognostic factors: the 3-fold classification by
treatment intention being the most important one, followed by physical functioning which may be seen as a
proxy for performance status. Several additional covariates including psychosocial ones were related to survival
when considered separately. However, their effects disappeared when controlling for treatment intention and
physical functioning. Thus, the additional psychosocial covariates did not add to the prognostic value of the
model.
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Many cancer treatments used today are unpleasant and the
burden they place on the patients may not be compensated
for by a longer survival time (Baum et al., 1990). Kaasa
(1993) reports for instance, that it is not unusual to offer
curative treatment to patients with inoperable non-small-cell
lung cancer, for which the 5 year survival is 1-2%
independent of treatment modality. So far, no agreement
exists on a definition of curable or non-curable cancer
diseases or how to treat the different patient groups (Kaasa,
1993). Therefore, a well-established classification of the
prognoses of the cancer patients is important both for
decisions on treatment and for avoiding overtreatment
(Henson, 1993).
There are several reasons for classifying malignant
tumours: diagnostic recognition, choice of therapy and to
provide prognostic information for patients and their families
(Fielding et al., 1992; Hermanek et al., 1990). The
classification most closely associated with prognosis is,
according to Hermanek et al. (1990), the anatomical extent
or stage of disease, which is defined according to the
T(umour) N(odes) M(etastasis) Classification of Cancer
(UICC, 1992). Although there is a good correlation between
TNM and prognosis, the problem of prognosis assessment is
not solved (Hermanek et al., 1989).
The prognosis of a cancer patient does not depend only on
the anatomical extent of the disease but also on tumour-
associated, patient-associated and treatment-associated fac-
tors (Hermanek et al., 1989, 1990). The results from several
studies have shown that the survival of cancer patients may
be predicted by an assessment of prognosis (Hermanek et al.,
1989; Chapuis et al., 1985) and also by prognostic-related
factors such as: sex and age (Griffin et al., 1989); general
symptoms (Kaasa et al., 1989); performance status, which
may be viewed as representing physical status (Stanley, 1980);
marital status (Ganz et al., 1991); psychosocial well-being
(Kaasa et al., 1989; Spiegel et al., 1989; Pettingale et al., 1985;
Greer et al., 1990; Greer, 1991); total quality of life scores
(Ganz et al., 1991; Coates, 1993); and tumour-associated
factors such as clinical or disease stage (Fielding et al., 1986;
Kaasa et al., 1989; Griffin et al., 1989; Stanley, 1980;
Freedman et al., 1979). Some studies have not found any
relationship between psychosocial aspects and the survival of
cancer patients (Cassileth et al., 1985, 1988, 1991; Ringdal,
1995).
The main purpose of this paper is to evaluate the
prognostic value of a 3-fold classification of cancer patients
by treatment intention compared with a number of other
clinical, demographic and psychosocial factors. The following
research questions will be pursued: Is the classification into
three groups by treatment intention significantly related to
survival of cancer patients? Are other clinical factors such as
treatment modality significantly related to survival of cancer
patients? Are demographic factors such as age, marital status
and having children significantly related to the survival of
cancer patients? Are psychosocial factors such as general
quality of life, anxiety and depression, hopelessness and
religiosity significantly related to the survival of cancer
patients?
Methods
Sanple characteristics
The sample is composed of253 hospitalised cancer patients at
the Department of Oncology, University Hospital of
Trondheim in Norway, who filled out a questionnaire. The
patients included in the sample had been informed of the
cancer diagnoses by their physician for a minimum of one
month. Very weak or dying patients were not included in the
sample. The data were obtained continuously from October
1991 to December 1992, and the response rate was 81%. The
most common reasons given by the patients for not
answering the questionnaire were that they felt too sick, or
that they felt uneasy and restless because of the disease or the
treatment.
The sample comprises 139 (55%) men and 114 (45%)
women aged 23 to 78 with a mean age of 57. The patients
came from the middle and northern parts of Norway. The
original classification into 17 different cancer diagnoses was
done by each patient's physician. This classification is
collapsed into six groups of diagnoses, ordered by the
survival rate as shown in Table I. The main reason behind
this grouping is to discriminate on potentially important
aspects for quality of life such as age, sex, the burden of
treatment, different kinds of treatments and the role of
specific symptoms.
The first group of patients (12%) is a mixture of several
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Table I Unixvariate survival analysis: descriptixe statistics and relatixve risks. n = 253
Descriptive statistics
n Wedian Ifean
Age
23-49
50-64
65-78
Sex
Female
Male
Treatment intention
Curatixve
PalliatiVe.
symptom-prexventix e
Palliatixve.
symptom-relieving
Phvsical functioning
High
Medium
Low-
Cancer type
Malignant melanoma. testis.
sarcomas. oxvanan cancer
Malignant lymphomas
Breast cancer
Other diagnoses (head
and neck. renal. brain)
Gastrointestinal cancer
Prostate. lung cancer
Treatment modalitx
Various
Radiotherapy
Cv-tostatics
Relapse
Check-up
Primarx treatment
Relapse 1
Relapse 2-
78
83
92
114
139
13
14
Rate
18.5 67
14.5 42
15.4 40
21 17.4
17 16.4
51
48
81 - 22.5 91
62 18 16.1 48
110 9 10.7 18
74
109
70
30
32
62
43
28
58
80
100
73
21
85
49
84
19
7
20.1 74
17.7 50
10.1 21
_ 19.9
21.9
18.1
14 16.0
12 14.1
9 11.9
- 16.0
18 16.7
16 16.4
22.7
21.5
14 15.3
8 11.2
77
75
53
47
36
24
56
47
44
90
74
43
20
p
0.00
0.45
0.00
0.00
0.00
CUniv-ariate Cox regression
RR Lovier L-pper
1.00 Ref. Ref.
2.00 1.24 3.25
1.94 1.21 3.11
1.00 Ref. Ref.
1.05 0.74 1.51
1.00 Ref. Ref.
7.32 3.22 16.64
15.91 7.34 34.49
1.00 Ref. Ref.
2.23 1.32 3.77
5.07 2.97 8.67
1.00
1.22 -1 "l
_.
3.02
3.86
4.86
0.55
1.00
1.34
1.44
0.00
Ref.
0.42
1.05
1.22
1.53
2.05
Ref.
0.85
0.90
Ref.
3.51
6.07
7.49
9.72
11.49
Ref.
2.11
2.32
1.00 Ref. Ref.
3.04 0.71 13.01
8.03 1.91 33.80
14.30 3.49 58.59
Median. median surix al time: Mean. mean survixval time: Rate. survival rate at 1 Februar- 1994: P.
probability- value of the log-rank statistic for the overall comparison of the Kaplan-Meier survixval
functions. Survival time is computed from the month ofdata collection. RR. eB. relatixve risk compared
with the reference category in unix ariate Cox regression analyses. B is the regression coefficient (not
reported). Lower. Upper. lower and upper limits ofconfidence inters-al of RR.
diagnoses: malignant melanomas. testicular cancer. different
sarcomas and ovarian cancer. The groups is characterised by
younger age. Although the different diagnoses imply
differences in prognosis in general. most of them are
characterised by treatment with curative intention, and
long-term and demanding treatment. It was felt reasonable
to group together patients With young age. uncertainty with
regard to long-term prognosis and hard. often multimodal
treatment in this context. The second group (13%) is
composed of patients with malignant lymphomas, charac-
tensed by variable prognoses and long-term toxic chemother-
apy. Breast cancer is the most frequent diagnosis (25% of all
included cases). 'Other diagnosis' (17%0) is a mixture of
several diagnoses (cancers of the head and neck. kidney.
bladder and brain cancer, and metastatic disease with
unknown origin) characterised by advanced stage. poor
prognosis and mainly palliative treatment (radiotherapy).
The fifth group (11%) is patients with gastrointestinal cancer
including anal cancer. characterised by the specific problems
ofhaving a stoma and other problems with natural functions.
Many of these patients have been given large field radio-
therapy in the abdominal area. The last group is a mixture of
prostate (12%) and lung cancer (11%). The two diagnoses
are grouped together because they are dominated by middle-
aged and old men. most often with a poor prognosis and
with minimal chances of survival and often with symptomatic
disease. In this context it should be mentioned that although
prostate cancer often shows protracted clinical course and
w-ith a rather long median survival in spite of disseminated
disease. many of the patients remitted for palliative radio-
therapy to the departments of oncology have a rather short
life expectancy.
The questionnaire
The questionnaire. with a total of 108 questions. includes in
order: the European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire
(EORTC QLQ-C30) (Aaronson et al.. 1993). the Hospital
Anxiety and Depression (HAD) scale (Zigmond and Snaith.
1983). the Hopelessness Scale (HS) (Beck et al.. 1974).
questions about religiosity (Ringdal. 1994). questions about
the economic situation. and sociodemographic background.
The EORTC QLQ-C30 was selected as the main quality of
life measure because it is multidimensional. cancer-specific.
designed for self-administration and intended for application
across a range of cancer diagnoses. The latter is of special
importance in this study. because it covers patients u-ith
different kinds of cancer diagnoses. Furthermore. the
EORTC QLQ-C30 is also relatixely short and has been
translated into different languages. The validity of the
Norwegian version of the EORTC QLQ-C30 is documented
in Ringdal and Ringdal (1993). Since the EORTC QLQ-C30
onlyr includes two items measuring anxiety and two items
measuring depression. we also included the Hospital Anxiety
and Depression (HAD) scale with seven items measuring
anxiety and seven items measuring depression. We chose the
HAD scale because it is designed for use in populations ofP. og dc fatrsi canoewar
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somatically ill patients. The Hopelessness scale was included
in the questionnaire because several studies on the relation-
ship between psychosocial characteristics and the survival of
cancer patients have focused on hopelessness (Greer et al.,
1990; Cassileth et al., 1985, 1988).
The assessment of clinical information
With the assistance of nurses, physicians and the patient's
journals, clinical data for each patient were recorded. Each
patient's physician completed a form for the 'Registration of
treatment objectives', developed at The Norwegian Radium
Hospital in Oslo, including items on diagnoses, treatment
modality and treatment intention. In addition, information
on the survival of the patients on 1 February 1994 was
obtained from the hospital records and the survival time was
computed.
Classification into groups by treatment intention
Without having knowledge of the patient's responses on the
questionnaire, each patient's physician completed a form for
the 'Registration of treatment objectives'. The last item
required the physician to place the patients in one of three
categories: treatment with curative intention, palliative
treatment against tumour tissue to prevent or delay
progression of the disease, or palliative treatment of
symptoms to alleviate the symptoms of the disease. The
latter category applies to patients with a short life expectancy.
A total of 32% of the patients received curative treatment,
25% received palliative, symptom-preventive treatment and
44% received palliative, symptom-relieving treatment.
Statistics
Kaplan-Meier survival functions (Blossfeld et al., 1989;
Norusis and SPSS, 1993) were used for univariate compar-
ison of the survival of groups by the prognostic factors.
Differences in survival functions were evaluated by means of
the log-rank test (Norusis and SPSS, 1993). Cox regression,
the proportional hazards model (Parmar and Machin, 1995;
Yamaguchi, 1991), was used to examine the relationship
between the prognostic factors and survival. In the tables, the
exponentiated values of the regression coefficients (RR) are
usually reported. For continuous covariates, RR is the
change in the hazard rate accompanied by a unit change in
the covariate. For categorical covariates, RR is the relative
risk of dying compared with the reference category where the
risk is set to 1.0. Values of RR below 1.0 mean lower relative
risks of dying than for the reference category, and values of
RR above 1.0 indicate higher risks than for the reference
category. Confidence intervals for the relative risks of dying
are also reported.
Results
Univariate survival analysis
We start by examining the univariate relationship of two
demographic variables: age and sex, and some clinical
factors: treatment intention, physical functioning, cancer
type, treatment modality and relapse, with survival.
Columns two to four of Table I show the median and mean
survival time in months starting from the month of the data
collection, and percentage surviving at 1 February 1994. The
middle column of the table labelled 'P' shows the probability
that the groups for each categorical covariate have identical
survival functions as measured by the log-rank statistic.
Age, collapsed into three categories (23-49, 50-64, 65-
78) is significantly related to survival (P<0.004). The main
reason for this is the longer survival and the higher survival
rates of the youngest category. The survival statistics for
females are not significantly better than for men (P>0.4).
The difference between the groups by treatment intention is
large; the survival rate, for instance, vary from 91% for the
curative intention group to 18% among those receiving
palliative, symptom-relieving treatment, and the overall
difference is highly significant (P<0.001).
The high, medium and low groups of physical functioning
show a similar pattern with survival rates varying from 21%
in the 'low' group to 74% in the 'high' group. The 3-fold
classification by physical functioning may be seen as a proxy
for performance status (Karnofsky et al., 1948). This
classification is a collapsed version of the five item physical
functioning subscale of the EORTC QLQ-C30. Also cancer
type comes out with a significant overall relationship. The
highest survival rate, 77%, is found among those with
malignant melanomas, testicular cancer, sarcomas and
ovarian cancer. The lowest survival rate of 24% is found in
the group of prostate and lung cancer. Table I further shows
that treatment modality is not significantly related to
survival, whereas relapse is significantly related to survival.
The survival rate varies from 90% for those who are in the
hospital for check-up to 20% for those with two or more
relapses.
The detailed evaluation of the potential prognostic factors
starts with univariate Cox regression analyses reported in the
three last columns of Table I, which display the estimates of
relative risks (RR) and the lower and upper limits of their
95% confidence interval.
The relative risk of dying for patients 50 years or older is
about twice that among patients in the youngest (23-49
years) age group. There are, however, only marginal and not
significant differences in the relative risks between male and
female patients. The relative risk of dying for the group
receiving palliative, symptom-preventive treatment is about
seven times higher than for those treated with curative
intention. The relative risk for those receiving palliative,
symptom-relieving treatment is estimated to be around 16
times higher compared with those treated with curative
intention. The relative risk of dying for the group of patients
with medium and low physical functioning is around two and
five respectively, compared with the group with high physical
functioning. Patients with prostate and lung cancer have an
estimated relative risk of dying of almost five compared with
the reference category (malignant melanomas, testicular
cancer, sarcomas, ovarian cancer). The relative risk of dying
for patients with gastrointestinal cancer is almost four times
higher than for the reference category. Also patients with
'Other diagnoses' and those with breast cancer have
significantly higher relative risks of dying than the reference
category. Treatment modality is not significantly related to
survival. Finally, the relative risks for dying increase with
relapse. For patients with one relapse, the relative risk is 8.0
compared with the reference category, those in for check-up,
and for those with two or more relapses the relative risk is
14.3.
Next, we will consider the prognostic value of some less
well-founded factors, mainly psychosocial ones. The follow-
ing factors are examined in a series of univariate Cox
regression analyses displayed in Table II: marital status,
having children, level of education, personal economic
situation, general quality of life (measured by the last item
in the EORTC QLQ-C30), social functioning, pain, fatigue
and cognitive functioning (measured by subscales in the
EORTC QLQ-C30), the HAD scale, the subscales of HAD
measuring anxiety and depression, the emotional functioning
scale from the EORTC QLQ-C30, a hopelessness scale (HS)
and a two item religiosity scale (Ringdal, 1994). The
sociodemographic factors at the top of the table are not
significantly related to survival. The subscales from the
EORTC QLQ-C30 of physical symptoms, pain and fatigue,
are significantly related to survival. The worse the symptoms,
the higher the relative risk of dying. Also, the social
functioning of the patients is related to survival. Most of
the scales of psychological factors, such as cognitive
functioning, depression, hopelessness and general quality of
life, are also significantly related to survival.Prognostic factors and survival, a multiple Cox regression
analysis
Having established the univariate relationship between a
range of potential prognostic factors and survival, the next
step is to examine how they perform in a multiple Cox
regression analysis. The pool ofvariables to be considered are
the best predictors of survival among the covariates presented
in Tables I and II. First, we used forward stepwise selection
among the prognostic factors that were found to be
statisticaly significant in Table I. This criterion included
only treatment intention and physical functioning in the
model. In the next step, we tried out the significant covariates
from Table II. Only hopelessness and general quality of life
were included in the model by the criterion of forward
stepwise selection. In the final Cox regression analysis, we
kept treatment intention and physical functioning in the
model along with cancer type and age, and tested if
hopelessness and general quality of life could be added to
the model by forward stepwise selection. It turned out that
none of them significantly improved upon the basic model.
Thus, the final model displayed in Table III has only two
significant covariates: treatment intention and physical
functioning. The effects of the two covariates are partly
Propiostic faCtors in cuice patisds
GI Pgdal et al Ps
1597
overlapping. However, leaving out physical functioning
reduces the explanatory power of the model only by around
10%. On the other hand, omitting treatment intention from
the model reduces the explanatory power of the model by
more than 50%.
The adjusted relative risk of dying for those receiving
palliative, symptom-preventive treatment is 6.6 and for those
receiving palliative, symptom-relieving treatment the relative
risk is 12.8, or close to 13 times higher than for the reference
category, patients treated with curative intention. Patients
with low physical functioning have an adjusted relative risk
of 2.2 compared with the reference category, those with high
scores on the physical functioning scale. Patients with
medium physical functioning do not however, differ
significantly from those with high physical functioning.
Finally, the survival functions for each of the groups by
treatment intention and physical functioning, based on the
final model with the remaining covariates set at their means,
are presented in Figures 1 and 2. There are three clearly
distinct curves with the one for those treated with curative
intention located far apart from the other two, indicating the
far better chances for survival in that group. In Figure 2 the
curve for the group with low physical functioning is clearly
different from the two remaining groups, whose survival
Table H Univariate Cox regression analysis (the proportional hazards model) with
mainly psychosocial covariates, n = 239
Covarates
1, married; 0, not married
1, have children; 0, no child
Level of education
1, low....4, high
Personal economy,
1, good; 2, medium; 3, bad
General quality of life
Social functioning scale
Pain (P)
Fatigue (F)
Cognitive functioning (CF)
Hospital anxiety and depression scale
HADS, subscale for anxiety
HADS, subscale for depression
Emotional functioning (EF)
Hopekssness scale
Religiosity scale
95% Confidence interval
RR Lower Upper
1.01 0.65 1.57
1.26 0.72 2.20
1.10 0.92 1.32
0.90 0.69
0.82
0.87
1.24
1.19
0.87
1.05
1.04
1.16
0.96
1.11
1.01
0.73
0.79
1.14
1.10
0.78
1.01
0.98
1.06
0.90
1.06
0.87
1.18
0.91
0.97
1.35
1.29
0.97
1.10
1.10
1.27
1.02
1.17
1.17
RR, eB, forcontinuous covariates RRisthechangein thehazard rateaccompanied by a
unit change in the covariate; for categorical covariates RR is the relative risk compared
with the reference category. 95% Confidence interval ofRR. Soc, Symp4, Symp6, Symp7
and Dep are quality of life scales based on the EORTC QLQ-C30 and documented in
Ringdal and Ringdal (1993).
Table m The main prognostic factors and survival: a multiple Cox regression analysis (the
proportional hazards model) with forward stepwise seection, controlling for age and cancer type
(n = 229)
95% Confudence interval
B P RR Lower LIpper
Treatment intention
Curative Ref. Ref. 1.00 Ref. Ref.
Palliative symptom-preventive 1.89 0.000 6.62 2.76 15.90
Palliative symptom-relieving 2.54 0.000 12.78 5.51 29.64
Physical functioning
High Ref. Ref. 1.00 Ref. Ref.
Medium 0.27 0.333 1.32 0.76 2.29
Low 0.81 0.005 2.24 1.27 3.95
B, the regressioncoefficient. P, theprobability value (two-tailed) ofB. RR, relative risk compared with
the reference category. RR = eB. Survival time is computed from the month of data collection until
death or I February 1994.
Married
Child
Ed
Econ
Qol
Soc
Symp4
Symp6
Symp7
HADS
HAD3
HAD4
Dep
HS
RelProcnoc factors in cancw padwft
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> 0.8;
i> 0.7
0 0.6
> 0.5-
X 0.4
0.3
3 0.2
0.1
0.0 00 . ... .. . . . .. . . . . . ..
0 5 10 15 20 25
Time (months)
Fugwe 1 Survival functions by treatment intention
palliative, symptom-relieving; - - - -, palliative, symptom-
preventive; -- -, curative), estimated from a Cox regression
with other covariates set to their means.
g 0.9
0.4
E o
C-)~ ~ ~ 3 > 0.2.
0.1
Time (months)
Fgre 2 Suvval functions by physical functioning (PF: ---,
high, -----, medium; , low), estimated from a Coxc
regression with other covariates set to their means.
curves are more similar. That means patients with low
physical functioning have significantly lower chances for
survival than those with medium or high physical function-
ing.
Dia
The purpose of this paper has been to examine the empirical
relationship between treatment intention and other prognos-
tic-related factors such as clinical, demographic and
psychosocial ones, and survival. The analyses indicate that
treatment intention and physical functioning are the main
prognostic factors in our heterogeneous population. The
predicted relative risk of dying for patients receiving
palliative, symptom-relieving treatment is 12.8, and 6.6 for
those receiving palliative, symptom-preventive treatment,
compared with those treated with curative intention. The
patients with low scores on physical functioning have a
relative risk of dying of 2.2 compared with those with high
scores on the physical functioning scale. Several psychosocial
factors were related to survival in the initial univariate
analyses, but the relationships disappeared when controlling
for clinical factors.
Stanley et al. (1980) found that initial performance status
was the dominant prognostic factor for survival. Performance
status in their study was measured by the Karnofsky
Performance Rating, consisting of 10 ordered levels of
physical impairment ranging from 100 (normal, no evidence
of disease) to 20 (very sick, hospitalisation necessary) and 0
(dead) (Karnofsky et al., 1948). Performance status overlaps
substantially in content with the self-reported measurement
of physical functioning in the EORTC QLQ-C30, and they
are correlated (Aaronson et al., 1993). Thus, our finding on
physical functioning is consistent with the results of Stanley
et al. (1980), with the qualification that our study points at
the classification into groups by treatment intention as the
most powerful prognostic factor.
The research literature diverges on the question of whether
psychosocial factors have prognostic value. Some studies are
consistent with our negative findings (Cassileth et al., 1985,
1988, 1991), while other studies have reported opposite
results (Kaasa et al., 1989; Spiegel et al., 1989; Pettingale et
al., 1985; Greer et al., 1990). The causal relationship of
psychosocial factors to survival is also problematic. If any
causal relationship exists, the causal direction may well be in
the opposite direction with the gravity of the disease
influencing the psychosocial factors.
The classification into three groups by treatment intention
was found to be the most important prognostic factor in this
study. This classification has the advantage of being
applicable to all cancer patients regardless of diagnoses.
Therefore, treatment intention as a prognostic factor seems
well worth following up in future studies.
Our study has, however, some shortcomings. The clinical
data are scarce. The registration of treatment history is rather
superficial, and the classification only pertains to the present
treatment, and no information was registered about the
frequencies and amount of treatments. Neither was disease
stage registered. However, our main goal was to test the
hypothesis whether the classification of treatment intention
was of prognostic importance. In-depth clinical information
on each patient requires restricting the analysis to patients
with identical diagnoses. Therefore, future studies in separate
diagnostic groups are needed to further substantiate the
prognostic value of the 3-fold classification of patients by
treatment intention.
It would also be interesting to refine this 3-fold
classification further. In another study from our group, a
fourth category is proposed, called 'Life-prolonging treat-
ment' (Kaasa et al., 1996). It would be of great interest to
perform a new study in patients only receiving non-curative
treatment and assess whether the three treatment intention
categories: life-prolonging treatment, palliative symptom-
preventive and palliative symptom-relieving treatment,
would be of prognostic significance.
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